Stoneburner Rand, Korenromp Eline, Lazenby Mark, Tassie Jean-Michel, Letebele Judith, Motlapele Diemo, Granich Reuben, Boerma Ties, Low-Beer Daniel
UNAIDS, Geneva, Switzerland.
The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands.
PLoS One. 2014 Jul 8;9(7):e100431. doi: 10.1371/journal.pone.0100431. eCollection 2014.
Botswana's AIDS response included free antiretroviral treatment (ART) since 2002, achieving 80% coverage of persons with CD4<350 cells/µl by 2009-10. We explored impact on mortality and HIV prevalence, analyzing surveillance and civil registration data.
Hospital natural cause admissions and deaths from the Health Statistics Unit (HSU) over 1990-2009, all-cause deaths from Midnight Bed Census (MNC) over 1990-2011, institutional and non-institutional deaths recorded in the Registry of Birth and Deaths (RBD) over 2003-2010, and antenatal sentinel surveillance (ANC) over 1992-2011 were compared to numbers of persons receiving ART. Mortality was adjusted for differential coverage and completeness of institutional and non-institutional deaths, and compared to WHO and UNAIDS Spectrum projections.
HSU deaths per 1000 admissions declined 49% in adults 15-64 years over 2003-2009. RBD mortality declined 44% (807 to 452/100,000 population in adults 15-64 years) over 2003-2010, similarly in males and females. Generally, death rates were higher in males; declines were greater and earlier in younger adults, and in females. In contrast, death rates in adults 65+, particularly females increased over 2003-2006. MNC all-age post-neonatal mortality declined 46% and 63% in primary and secondary level hospitals, over 2003-2011. We estimated RBD captured 80% of adult deaths over 2006-2011. Comparing empirical, completeness-adjusted deaths to Spectrum estimates, declines over 2003-2009 were similar overall (47% vs. 54%); however, Spectrum projected larger and earlier declines particularly in women. Following stabilization and modest decreases over 1998-2002, HIV prevalence in pregnant women 15-24 and 25-29-years declined by >50% and >30% through 2011, while continuing to increase in older women.
Adult mortality in Botswana fell markedly as ART coverage increased. HIV prevalence declines may reflect ART-associated reductions in sexual transmission. Triangulation of surveillance system data offers a reasonable approach to evaluate impact of HIV/AIDS interventions, complementing cohort approaches that monitor individual-level health outcomes.
自2002年以来,博茨瓦纳的艾滋病应对措施包括免费抗逆转录病毒治疗(ART),到2009 - 2010年,CD4细胞计数<350个/微升的人群覆盖率达到了80%。我们通过分析监测和民事登记数据,探讨了其对死亡率和艾滋病毒流行率的影响。
比较了1990 - 2009年卫生统计股(HSU)的医院自然病因入院人数和死亡人数、1990 - 2011年午夜床位普查(MNC)的全病因死亡人数、2003 - 2010年出生和死亡登记处(RBD)记录的机构和非机构死亡人数,以及1992 - 2011年的产前哨点监测(ANC)与接受抗逆转录病毒治疗的人数。对机构和非机构死亡的差异覆盖率和完整性进行了死亡率调整,并与世界卫生组织和联合国艾滋病规划署的Spectrum预测进行了比较。
在2003 - 2009年期间,15 - 64岁成年人中,每1000例入院患者的HSU死亡人数下降了49%。在2003 - 2010年期间,RBD死亡率下降了44%(15 - 64岁成年人中从每10万人807例降至452例),男性和女性情况类似。一般来说,男性的死亡率较高;年轻人以及女性的死亡率下降幅度更大且更早。相比之下,65岁及以上成年人,尤其是女性的死亡率在2003 - 2006年期间有所上升。在2003 - 2011年期间,一级和二级医院中MNC全年龄新生儿后期死亡率分别下降了46%和63%。我们估计RBD在2006 - 2011年期间记录了80%的成人死亡。将经完整性调整后的实际死亡人数与Spectrum估计值进行比较,2003 - 2009年期间总体下降情况相似(47%对54%);然而,Spectrum预测的下降幅度更大且更早,尤其是在女性中。在1998 - 2002年稳定并略有下降之后,15 - 以及25 - 29岁孕妇中的艾滋病毒流行率在2011年之前分别下降了超过50%和超过30%,而老年女性中的流行率仍在继续上升。
随着抗逆转录病毒治疗覆盖率增加,博茨瓦纳的成人死亡率显著下降。艾滋病毒流行率的下降可能反映了抗逆转录病毒治疗对性传播的减少作用。监测系统数据的三角测量法为评估艾滋病毒/艾滋病干预措施的影响提供了一种合理方法,补充了监测个体健康结果的队列研究方法。